BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35730400)

  • 1. Biomarkers of caspofungin resistance in
    De Cesare GB; Hafez A; Stead D; Llorens C; Munro CA
    Virulence; 2022 Dec; 13(1):1005-1018. PubMed ID: 35730400
    [No Abstract]   [Full Text] [Related]  

  • 2. Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies.
    Perrine-Walker F
    Braz J Microbiol; 2022 Sep; 53(3):1101-1113. PubMed ID: 35352319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin and caspofungin show synergistic antifungal effects in caspofungin-susceptible and caspofungin-resistant Candida strains in vitro.
    Lefranc M; Accoceberry I; Fitton-Ouhabi V; Biteau N; Noël T
    J Antimicrob Chemother; 2024 Jan; 79(1):151-156. PubMed ID: 37991226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspofungin dose escalation for invasive candidiasis due to resistant Candida albicans.
    Wiederhold NP; Najvar LK; Bocanegra RA; Kirkpatrick WR; Patterson TF
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3254-60. PubMed ID: 21502632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypic and phenotypic characterization of Candida albicans Lebanese hospital isolates resistant and sensitive to caspofungin.
    Toutounji M; Tokajian S; Khalaf RA
    Fungal Genet Biol; 2019 Jun; 127():12-22. PubMed ID: 30794951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspofungin-induced β(1,3)-glucan exposure in
    Wagner AS; Lumsdaine SW; Mangrum MM; Reynolds TB
    mBio; 2023 Aug; 14(4):e0007423. PubMed ID: 37377417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Genes of Candida albicans Influencing Echinocandin Susceptibility in Caspofungin-Adapted Mutants.
    Sah SK; Bhattacharya S; Yadav A; Husain F; Ndiaye ABKT; Kruppa MD; Hayes JJ; Rustchenko E
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0097722. PubMed ID: 36354349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata.
    Ceballos-Garzon A; Monteoliva L; Gil C; Alvarez-Moreno C; Vega-Vela NE; Engelthaler DM; Bowers J; Le Pape P; Parra-Giraldo CM
    J Antimicrob Chemother; 2022 Feb; 77(3):585-597. PubMed ID: 34893830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.
    Brzankalski GE; Najvar LK; Wiederhold NP; Bocanegra R; Fothergill AW; Rinaldi MG; Pattterson TF; Graybill JR
    J Antimicrob Chemother; 2008 Nov; 62(5):1094-100. PubMed ID: 18658194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to caspofungin is regulated by temperature and is dependent on calcineurin in
    Zheng L; Xu Y; Wang C; Yang F; Dong Y; Guo L
    Microbiol Spectr; 2023 Dec; 11(6):e0179023. PubMed ID: 37966204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
    Park S; Kelly R; Kahn JN; Robles J; Hsu MJ; Register E; Li W; Vyas V; Fan H; Abruzzo G; Flattery A; Gill C; Chrebet G; Parent SA; Kurtz M; Teppler H; Douglas CM; Perlin DS
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates.
    Walraven CJ; Bernardo SM; Wiederhold NP; Lee SA
    Med Mycol; 2014 Feb; 52(2):131-139. PubMed ID: 24576999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting Fungal Echinocandin Resistance by Small-Molecule Disruption of Geranylgeranyltransferase Type I Activity.
    Sun Q; Xiong K; Yuan Y; Yu J; Yang L; Shen C; Su C; Lu Y
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31791942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of
    Yang F; Zhang L; Wakabayashi H; Myers J; Jiang Y; Cao Y; Jimenez-Ortigosa C; Perlin DS; Rustchenko E
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata.
    Vatanshenassan M; Boekhout T; Lass-Flörl C; Lackner M; Schubert S; Kostrzewa M; Sparbier K
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 30021820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae.
    Zhang J; Silao FG; Bigol UG; Bungay AA; Nicolas MG; Heitman J; Chen YL
    PLoS One; 2012; 7(8):e44192. PubMed ID: 22952924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.
    Desnos-Ollivier M; Bretagne S; Raoux D; Hoinard D; Dromer F; Dannaoui E;
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3092-8. PubMed ID: 18591282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).
    Kritikos A; Neofytos D; Khanna N; Schreiber PW; Boggian K; Bille J; Schrenzel J; Mühlethaler K; Zbinden R; Bruderer T; Goldenberger D; Pfyffer G; Conen A; Van Delden C; Zimmerli S; Sanglard D; Bachmann D; Marchetti O; Lamoth F;
    Clin Microbiol Infect; 2018 Nov; 24(11):1214.e1-1214.e4. PubMed ID: 29909005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cell wall protein Rhd3/Pga29 is over-expressed in Candida albicans upon micafungin treatment.
    Vavala E; Mignogna G; Spano F; Stringaro A; Colone M; Sanguinetti M; Maras B; Angiolella L
    J Chemother; 2013 Dec; 25(6):332-40. PubMed ID: 24090751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.